Review article: remission rates achievable by current therapies for inflammatory bowel disease. [electronic resource]
- Alimentary pharmacology & therapeutics Apr 2011
- 870-9 p. digital
Publication Type: Journal Article; Review
1365-2036
10.1111/j.1365-2036.2011.04599.x doi
Adrenal Cortex Hormones--therapeutic use Anti-Bacterial Agents--therapeutic use Antibodies, Monoclonal--therapeutic use Azathioprine--therapeutic use Enteral Nutrition Humans Inflammatory Bowel Diseases--drug therapy Infliximab Methotrexate--therapeutic use Remission Induction Tumor Necrosis Factor-alpha--antagonists & inhibitors